Spotlight on landmark oncology trials: the latest evidence and novel trial designs
Abstract The era of precision oncology is marked with prominent successes in the therapy of advanced soft tissue sarcomas, breast cancer, ovarian cancer and haematological neoplasms, among others. Moreover, recent trials of immune checkpoint inhibitors in melanoma, non-small cell lung carcinoma, and...
Main Authors: | Helena Earl, Stefano Molica, Piotr Rutkowski |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12916-017-0884-7 |
Similar Items
-
Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials
by: Raftery James, et al.
Published: (2012-08-01) -
Methodology series module 4: Clinical trials
by: Maninder Singh Setia
Published: (2016-01-01) -
Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials
by: Eliya Farah, et al.
Published: (2023-09-01) -
Design considerations for clinical trials in aphasia
by: Rebecca Palmer
Published: (2020-01-01) -
Managing clustering effects and learning effects in the design and analysis of randomised surgical trials: a review of existing guidance
by: Elizabeth J. Conroy, et al.
Published: (2022-10-01)